Go to All Subject -

Modern Pharmacology with Clinical Applications -

Online Study Material, Lecturing Notes, Assignment, Reference, Wiki and important questions and answers

Modern Pharmacology with Clinical Applications
-:- Progress in Therapeutics: Contributions of Many Cultures
-:- Drug Control And Development
-:- Modern Drug Legislation
-:- Clinical Testing of Drugs
-:- Phases of Clinical Investigation
-:- Special Populations
-:- Adverse Reaction Surveillance
-:- Receptors
-:- Drug Receptors and Biological Responses
-:- Second-Messenger Systems
-:- The Chemistry of Drug-Receptor Binding
-:- Dynamics of Drug–Receptor Binding
-:- Dose–Response Relationship
-:- Equations Derived From Drug–Receptor Interactions
-:- Drug Antagonism
-:- Properties of Biological Membranes that Influence Drug Passage
-:- Mechanisms of Solute Transport Across Membranes
-:- Absorption of Drugs From the Alimentary Tract
-:- Factors Affecting Rate of Gastrointestinal Absorption
-:- Absorption of Drugs From the Lung
-:- Absorption of Drugs Through the Skin
-:- Absorption of Drugs After Parenteral Administration
-:- Factors Influencing Drug Distribution
-:- Human Available Distribution Volume
-:- Binding of Drugs to Plasma Proteins
-:- Selective Accumulation of Drugs
-:- Physiological Barriers to Drug Distribution
-:- Oxidative and Reductive Enzymes: Phase I Reactions
-:- Conjugative Enzymes: Phase II Reactions
-:- Tissue Specificity of Human Drug Metabolism Enzymes
-:- Pharmacogenetics of Drug-Metabolizing Enzymes
-:- Excretion of Drugs
-:- Renal Excretion
-:- Pulmonary Excretion
-:- Excretion in Other Body Fluids
-:- Pharmacokinetics
-:- Drug Concentration-Time Profiles and Basic Pharmacokinetic Parameters
-:- Additional Pharmacokinetic Parameters
-:- Pharmacokinetics of Single Versus Multiple Dosing
-:- Nonlinear Pharmacokinetics
-:- Drug Disposition in Pediatric Patients
-:- Drug Disposition in Geriatric Patients
-:- Principles of Toxicology
-:- Manifestations of Toxicity
-:- Treatment of Poisonings
-:- Exposure to Nontherapeutic Toxicants
-:- Applications of Toxicological Principles
-:- Biomedical Ethics in Pharmacology: An Introduction and Framework
-:- Biomedical Ethics and Clinical Research
-:- Conflicts of Interest and the Pharmaceutical Industry
-:- General Organization and Functions of the Nervous System
-:- Anatomic Differences Between the Somatic and Autonomic Nervous Systems
-:- Autonomic Nervous System
-:- Autonomic Neurotransmitters
-:- Innervation of Various Organs by the Sympathetic and Parasympathetic Nervous Systems
-:- The Adrenal Medulla
-:- Transmission of the Nerve Impulse
-:- Steps in Neurochemical Transmission
-:- Receptors on the Autonomic Effector Cells
-:- Adrenomimetic Drugs: Chemistry
-:- Adrenomimetic Drugs: Mechanism of Action
-:- Pharmacodynamic Actions of Norepinephrine, Epinephrine, and Isoproterenol
-:- Pharmacological Actions of Dopamine
-:- Clinical Uses of Catecholamines
-:- Other Adrenomimetic Agents
-:- Adrenoceptors
-:- Classification of Blocking Drugs
-:- alpha-Receptor Blocking Agents
-:- beta-Adrenoceptor Blocking Agents
-:- Drugs With Combined and Βeta-and Αlpha Blocking Activity
-:- Directly and Indirectly Acting Cholinomimetics
-:- Direct-Acting Parasympathomimetic Drugs
-:- Cholinesterase Inhibitors
-:- Cholinesterase Inhibitors: Clinical Uses
-:- Muscarinic Blocking Drugs: Chemistry
-:- Muscarinic Blocking Drugs: Mechanism of Action
-:- Muscarinic Blocking Drugs: Pharmacological Actions
-:- Muscarinic Blocking Drugs: Absorption, Metabolism, and Excretion
-:- Muscarinic Blocking Drugs: Clinical Uses
-:- Muscarinic Blocking Drugs: Antimuscarinic Poisoning
-:- Muscarinic Blocking Drugs: Contraindications and Cautions
-:- Ganglionic Transmission
-:- Ganglionic Stimulants
-:- Ganglionic Blocking Drugs
-:- Individual Agents
-:- Chronic (Congestive) Heart Failure
-:- Myocardial Excitation–Contraction Coupling
-:- Cardiac Glycosides
-:- Diuretics
-:- Hydralazine and Nitrates
-:- Angiotensin-Converting Enzyme Inhibitors
-:- Beta-Adrenoceptor Blocking Drugs
-:- cAMP-Elevating Agents
-:- Antiarrhythmic Drugs
-:- Cardiac Electrophysiology: Transmembrane Potential
-:- Cardiac Electrophysiology: Ionic Basis for the Membrane Action Potential
-:- Cardiac Electrophysiology: Automaticity
-:- Cardiac Electrophysiology: Cardiac Conduction
-:- Cardiac Electrophysiology: Refractory Period
-:- Cardiac Electrophysiology: Mechanisms of Arrhythmias
-:- Cardiac Electrophysiology: Enhanced Automaticity
-:- Cardiac Electrophysiology: Triggered Activity
-:- Cardiac Electrophysiology: Reentry
-:- Classification of Antiarrhythmic Drugs
-:- Quinidine
-:- Procainamide
-:- Disopyramide
-:- Moricizine
-:- Lidocaine
-:- Phenytoin
-:- Tocainide
-:- Mexiletine
-:- Flecainide
-:- Propafenone
-:- Propranolol
-:- Acebutolol
-:- Esmolol
-:- Bretylium
-:- Amiodarone
-:- Sotalol
-:- Dofetilide
-:- Ibutilide Fumarate
-:- Verapamil
-:- Digitalis Glycosides and Vagomimetic Drugs
-:- Adenosine
-:- Magnesium Sulfate
-:- Drug–Device Interactions
-:- Antianginal Drugs
-:- The Therapeutic Objectives in the Use of Antianginal Drugs
-:- Organic Nitrates Antianginal Drugs
-:- β-Adrenoceptor Blocking Agents
-:- Calcium Entry or Calcium Channel Blockers
-:- The Renin–Angiotensin System
-:- Angiotensin Receptors
-:- Pharmacological Actions
-:- Antagonists of the Renin–Angiotensin System
-:- Aldosterone
-:- Bradykinin
-:- Endothelin
-:- Natriuretic Peptides
-:- Nitric Oxide
-:- Calcium Channel Blockers
-:- Calcium Antagonism
-:- Pharmacological Effects on the Cardiovascular System
-:- Therapeutic Applications
-:- Calcium Channel Blockers: Pharmacokinetics
-:- Calcium Channel Blockers: Toxicity
-:- Antihypertensive Drugs
-:- Diuretics
-:- Vasodilators
-:- Vasodilators: Mechanism of Action
-:- Vasodilators: Hydralazine
-:- Vasodilators: Minoxidil
-:- Vasodilators: Diazoxide
-:- Vasodilators: Sodium Nitroprusside
-:- Drugs That Impair Sympathetic Nervous System Functioning
-:- Adrenoceptor Antagonists
-:- Adrenergic Neuron Βeta-Blocking Drugs
-:- Drugs that Interfere with Norepinephrine Storage
-:- Drugs that Interfere with Norepinephrine Synthesis
-:- Ganglionic Blocking Agents
-:- Centrally Acting Hypotensive Drugs
-:- Diuretic Drugs
-:- Body Water and Electrolyte Metabolism
-:- Carbonic Anhydrase Inhibitors
-:- Thiazide Diuretics
-:- Hypokalemia and Potassium-sparing Diuretics
-:- High-Ceiling, or Loop, Diuretics
-:- Osmotic Diuretics
-:- Uses of Diuretics
-:- Hemostatic Mechanisms
-:- Coagulation Systems
-:- Anticoagulant Drugs
-:- Clinical Indications for Anticoagulant Therapy
-:- Antiplatelet Drugs
-:- Fibrinolytic System
-:- Prevention of Coronary Heart Disease as the Goal
-:- When to Treat Hypercholesterolemias?
-:- Management of Hyperlipidemias With Drugs
-:- Management of Hyperlipidemias With Drugs: Other Hypocholesterolemic Drugs
-:- When to Treat Hypertriglyceridemias
-:- Review of Basic Neuroscience
-:- Central Nervous System Neurotransmitters
-:- Blood-Brain Barrier
-:- Pharmacokinetic Characteristics Influencing the Clinical
-:- Intravenous Anesthetic Agents
-:- Benzodiazepines
-:- Etomidate
-:- Propofol
-:- Ketamine
-:- Intravenous Anesthetic Techniques Managed with Opioids
-:- α2-Adrenoceptor Agonists
-:- Inhalational Anesthetics
-:- Pharmacokinetic Characteristics
-:- Development of the Partial Pressure of a Gas in Solution
-:- A Concept of Anesthetic Dose Based on Partial Pressure–Minimum Alveolar Concentration
-:- Factors Affecting the Rate of Development of Anesthetic Concentration in the Lung
-:- Halogenated Hydrocarbon Anesthetics
-:- Nonhalogenated Inhalational Anesthetics
-:- Mechanism of Anesthetic Action
-:- The Nature of Pain
-:- Nonopioid Analgesics
-:- Salicylates
-:- p-Aminophenol Derivatives
-:- Indoles (indomethacin) and Related Compounds
-:- Fenamates
-:- Arylpropionic Acid Derivatives
-:- Pyrazolone Derivatives
-:- Oxicam Derivatives
-:- Acetic Acid Derivatives
-:- COX-2 Inhibitors
-:- Opioid Analgesics
-:- Opioid Analgesics: Pharmacological Effects
-:- Opioid Analgesics: Morphine
-:- Opioid Analgesics: Codeine and Other Phenanthrene Derivatives
-:- Opioid Analgesics: Meperidine and Related Phenylpiperidine Derivatives
-:- Opioid Analgesics: Fentanyl, Sufentanil, and Alfentanil
-:- Opioid Analgesics: Levorphanol
-:- Opioid Analgesics: Methadone
-:- Opioid Analgesics: Propoxyphene
-:- Opioid Analgesics: Opium-Containing Preparations
-:- Opioid Analgesics: Heroin
-:- Mixed Opioid Agonist–Antagonists or Partial Agonists
-:- Opioid Analgesics: Opioid Antagonists
-:- Opioid Analgesics: Drugs Used Predominantly as Antitussives
-:- Properties of Local Anesthetics
-:- Esters
-:- Amides
-:- Topical Agents
-:- Agents Affecting Neuromuscular Transmission
-:- Enhancement of Acetylcholine Release
-:- Depression of Acetylcholine Release
-:- Depression of Postjunctional Response to Acetylcholine
-:- Neuromuscular Blocking Agents
-:- Pharmacology of Antispasticity Agents
-:- Central Nervous System Stimulants
-:- Analeptic Stimulants
-:- Psychomotor Stimulants
-:- Xanthines
-:- Sedative–hypnotic and Anxiolytic Drugs
-:- Azapirones
-:- Benzodiazepines
-:- Other Benzodiazepine Receptor Agonists
-:- Sedatives and Anxiolytics With Other Major Uses
-:- Older Sedative–Hypnotic and Anxiolytic Agents
-:- Nonprescription Drugs
-:- Parkinson’s Disease
-:- Therapy of Parkinsonism
-:- Alzheimer’s Disease
-:- Antiepileptic Drugs
-:- Clinically Useful Drugs
-:- Sodium Channel Blocking Agents
-:- Drugs That Primarily Enhance the Action of GABA
-:- Agents That Block T-Calcium Channels
-:- Agents Whose Mechanism of Action Is Not Known
-:- Anticonvulsant Drugs and Pregnancy
-:- Treatment of Febrile Seizures
-:- Treatment of Status Epilepticus
-:- Treatment of Major Depression
-:- Treatment of Major Depression: The Selective Serotonin Reuptake Inhibitors
-:- Treatment of Major Depression: Miscellaneous Antidepressants
-:- Treatment of Major Depression: Tricyclic Antidepressants
-:- Treatment of Major Depression: Monoamine Oxidase Inhibitors
-:- Treatment of Manic-Depressive Illness
-:- The Disease of Schizophrenia
-:- Antipsychotic Mechanisms of Action
-:- Antipsychotic Drugs: Pharmacology
-:- Antipsychotic Drugs: Clinical Uses
-:- Antipsychotic Drugs: Adverse Effects
-:- Antipsychotic Drugs: Drug Interactions
-:- Contemporary Drug Abuse
-:- Opioids
-:- Stimulants
-:- Nicotine
-:- Sedative–Hypnotics
-:- Contemporary Drug Abuse: Ethanol
-:- Contemporary Drug Abuse: Marijuana
-:- Contemporary Drug Abuse: Hallucinogens
-:- Contemporary Drug Abuse: Inhalants
-:- Contemporary Drug Abuse: Designer Drugs
-:- Contemporary Drug Abuse: Anabolic Steroids
-:- Antiinflammatory and Antirheumatic Drugs
-:- The Inflammatory Process
-:- Nonsteroidal Antiinflammatory Drugs
-:- Specific Nonsteroidal Antiinflammatory Drugs
-:- Disease-Modifying Antirheumatic Drugs
-:- Methotrexate
-:- Sulfasalazine
-:- Antimalarials
-:- Leflunomide
-:- TNF-α : Inhibitors
-:- Interleukin-1 Antagonists
-:- Gold Compounds Drugs
-:- Other Drugs for Rheumatoid Arthritis Therapy
-:- New Approaches to the Treatment of Rheumatoid Arthritis
-:- Drugs Used in Gout
-:- Chemistry of Uric Acid
-:- Renal Urate Homeostasis
-:- Relationship of Uric Acid Levels to Gout
-:- Role of Phagocytosis in Acute Gouty Arthritis
-:- Principles of Gout Management
-:- Colchicine
-:- Uricosuric Agents
-:- Histamine
-:- Histamine Antagonism and Histamine Antagonists
-:- Drugs Used in Asthma
-:- Drugs Used in Asthma: Treatment Strategy
-:- Bronchodilators
-:- Adrenomimetic Agents
-:- Theophylline
-:- Anticholinergics
-:- Antiinflammatory Agents
-:- Alternative Therapies
-:- Status Asthmaticus
-:- Introduction to Normal Physiology
-:- Drugs That Increase GI Motility
-:- Drugs That Decrease GI Motility
-:- Pharmacological Modulation of Diarrhea
-:- Pharmacological Modulation of Vomiting
-:- Drugs that Decrease or Neutralize Gastric Acid Secretion
-:- Treatment of Inflammatory Bowel Disease
-:- Miscellaneous GI Drugs
-:- Skin Structure
-:- Percutaneous Absorption
-:- Practical Considerations in Topical Drug Therapy
-:- Topical Glucocorticosteroids
-:- Retinoids
-:- Photochemotherapy
-:- Photodynamic Therapy
-:- Aminolevulinic Acid
-:- Dapsone
-:- Thalidomide
-:- Antimalarial Drugs
-:- Antimicrobial Agents
-:- Drugs For Cutaneous Fungal Infections
-:- Drugs For Cutaneous Viral Infections
-:- Drugs Used To Treat Scabies and Lice
-:- Cytotoxic and Immunosuppressive Agents
-:- Topical Immune-Modulating Agents
-:- Antihistamines
-:- Doxepin
-:- Drugs Used to Treat Disorders of Pigmentation
-:- Recombinant Proteins and Other Biologicals
-:- Miscellaneous Topical Agents
-:- Keratolytics
-:- Sunscreens
-:- The Role of Supragingival Dental Plaque in the Initiation of Gingivitis
-:- Pharmacokinetics of the Oral Cavity
-:- Antiplaque Agents
-:- Introduction to Chemotherapy
-:- The Patient–Drug–Pathogen Interaction
-:- Managing Chemotherapy
-:- Sulfonamides
-:- Trimethoprim
-:- Quinolones: Nalidixic Acid and Fluoroquinolones
-:- Urinary Antiseptics
-:- β-Lactam Antibiotics
-:- β-Lactam Antibiotics: Mechanism of Action
-:- β-Lactam Antibiotics: Mechanisms of Resistance
-:- Penicillins
-:- Cephalosporins
-:- Carbapenems and Carbacephems
-:- Monobactams
-:- Aminoglycoside Antibiotics: Chemistry
-:- Aminoglycoside Antibiotics: Mechanism of Antibacterial Action
-:- Aminoglycoside Antibiotics: Mechanism of Antibacterial Resistance
-:- Aminoglycoside Antibiotics: Pharmacokinetics
-:- Aminoglycoside Antibiotics: Clinical Uses
-:- Aminoglycoside Antibiotics: Single Daily Dosing
-:- Aminoglycoside Antibiotics: Toxicity
-:- Tetracyclines
-:- Chloramphenicol
-:- Macrolide Antibiotics
-:- Lincosamides
-:- Bacitracin
-:- Glycopeptides: Vancomycin and Teicoplanin
-:- The Polymyxins
-:- Key Concepts in the Treatment of Tuberculosis
-:- First-Line Antituberculosis Drugs
-:- Second-Line Antituberculous Drugs
-:- Recommendation for the Treatment of Latent Tuberculosis Infection
-:- Recommendations for Treatment of Active Tuberculosis
-:- Treatment of Leprosy
-:- Viral Infection and Disease
-:- Antiherpesvirus Agents
-:- Antiherpesvirus Agents: Acyclovir and Valacyclovir
-:- Antiherpesvirus Agents: Cidofovir
-:- Antiherpesvirus Agents: Docosanol
-:- Antiherpesvirus Agents: Famciclovir and Penciclovir
-:- Fomivirsen
-:- Antiherpesvirus Agents: Foscarnet
-:- Antiherpesvirus Agents: Ganciclovir and Valganciclovir
-:- Antiherpesvirus Agents: Idoxuridine
-:- Antiherpesvirus Agents: Trifluridine
-:- Antiherpesvirus Agents: Vidarabine
-:- Antiinfluenza Agents
-:- Antiinfluenza Agents: Amantadine and Rimantadine
-:- Antiinfluenza Agents: Oseltamivir
-:- Antiinfluenza Agents: Zanamivir
-:- Antiviral Agents: Immune Globulin
-:- Antiviral Agents: Interferons
-:- Antiviral Agents: Ribavirin
-:- Antiviral Agents: Lamivudine
-:- Antiviral Agents: Palivizumab
-:- Human Immunodeficiency Virus
-:- Drug Therapy of HIV Infection
-:- Drug Therapy of HIV Infection: Nucleoside Reverse Transcriptase Inhibitors
-:- Drug Therapy of HIV Infection: Nucleotide Reverse Transcriptase Inhibitors
-:- Drug Therapy of HIV Infection: Nonnucleoside Reverse Transcriptase Inhibitors
-:- Drug Therapy of HIV Infection: Protease Inhibitors
-:- The Use of Antiretroviral Drugs in Pregnancy
-:- Antifungal Drugs
-:- Amphotericin B
-:- Nystatin Antifungal Drug
-:- The Azoles Antifungal Drug
-:- Fluconazole Antifungal Drug
-:- Itraconazole Antifungal Drug
-:- Ketoconazole Antifungal Drug
-:- Miconazole Antifungal Drug
-:- Clotrimazole Antifungal Drug
-:- Voriconazole Antifungal Drug
-:- Flucytosine Antifungal Drug
-:- Capsofungin Antifungal Drug
-:- Allylamines Antifungal Drug
-:- Griseofulvin Antifungal Drug
-:- Miscellaneous Topical Antifungal Agents
-:- Protozoal Diseases
-:- Antiprotozoal Drug: Metronidazole
-:- Antiprotozoal Drug: Iodoquinol
-:- Antiprotozoal Drug: Diloxanide Furoate
-:- Antiprotozoal Drug: Antibiotics
-:- Antiprotozoal Drug: Pentamidine
-:- Antiprotozoal Drug: Suramin
-:- Antiprotozoal Drug: Eflornithine
-:- Antiprotozoal Drug: Arsenicals
-:- Antiprotozoal Drug: Nifurtimox
-:- Antiprotozoal Drug: Antimonials
-:- Malaria
-:- Antimalarial Drugs
-:- Antimalarial Drugs In Development
-:- Selection of Antimalarial Drugs
-:- Anthelmintic Drugs
-:- Treatment for Infections Caused by Nematodes
-:- Benzimidazoles
-:- Treatment for Infections Caused by Cestodes
-:- Treatment for Infections Caused by Trematodes
-:- Concepts in Tumor Cell Biology
-:- Drugs and the Cell Cycle
-:- Tumor Growth and Growth Fraction
-:- The Log Cell Kill Hypothesis
-:- Cancer Chemotherapy: Drug Resistance
-:- Cancer Therapy and the Immune System
-:- General Toxicological Properties of Anticancer Drugs
-:- Pharmacokinetic Considerations in Cancer Chemotherapy
-:- Combination Chemotherapy
-:- Alkylating Agents
-:- Alkylating Agents: Nitrogen Mustards
-:- Alkylating Agents: Nitrosoureas
-:- Alkylating Agents: Alkyl Sulfonates
-:- Alkylating Agents: Ethylenimines
-:- Alkylating Agents: Triazenes
-:- Antimetabolites: Folate Antagonists
-:- Antimetabolites: Purine Analogues
-:- Antimetabolites: Pyrimidine Analogues
-:- Antineoplastic Agents: Antibiotics
-:- Antineoplastic Agents: Plant-Derived Products
-:- Antineoplastic Agents: Enzymes
-:- Antineoplastic Agents: Hormone Derivatives
-:- Antineoplastic Agents: Miscellaneous Agents
-:- Immunomodulating Agents
-:- Cellular Growth Factors
-:- New Drug Therapies for Cancer
-:- Autoimmune Diseases
-:- Organ Transplantation
-:- Primary Immunodeficiency Diseases
-:- General Principles of Immunosuppressive Therapy
-:- Individual Drugs Used to Suppress the Immune System
-:- Individual Drugs Used to Stimulate the Immune System
-:- Gene Therapy
-:- Gene Therapy: Definition and Goals
-:- Antisense
-:- Gene Excision and Replacement
-:- Gene Addition
-:- Gene Therapy: Delivery Systems
-:- Disease Application and Future Directions
-:- Anterior Pituitary Hormones
-:- Hypothalamic Regulatory Hormones
-:- Hormones of the Posterior Pituitary Gland
-:- Steroid Physiology
-:- Actions of the Corticosteroids
-:- General Pharmacology of Corticosteroids
-:- Adverse Effects
-:- Therapeutic Uses of Steroid Hormones
-:- Proposed Mechanism of Steroid Action
-:- Drugs Used in the Diagnosis or Treatment of Adrenocortical Abnormalities
-:- Natural Estrogens and Progestins
-:- Natural Estrogens and Progestins: Mechanisms of Action
-:- Actions of Estrogens and Progestins in Females
-:- Synthetic Agents Acting Via Estrogen and Progesterone Receptors
-:- Selective Estrogen Receptor Modulators (SERMs)
-:- Selective Estrogen Receptor Modulators (SERMs): Clinical Uses
-:- Cancer
-:- Other clinical uses of estrogens and progestins
-:- Estrogens, Progestins: Adverse Effects
-:- Contraindications and Drug Interactions
-:- Uterine Stimulants and Relaxants
-:- Uterine Stimulants
-:- Uterine Relaxants
-:- Characterization of Plasma Androgens
-:- Sex Hormone–Binding Proteins
-:- Steroidogenesis
-:- Regulation of Plasma Testosterone
-:- Androgen: Mechanism of Action
-:- Androgens: Pharmacological Actions
-:- Androgens: Clinical Uses
-:- Androgens: Adverse Effects
-:- Androgens: Antiandrogens
-:- Drugs Used in the Treatment of Erectile Dysfunction
-:- Physiology of Penile Erection
-:- Individual Agents
-:- Thyroid and Antithyroid Drugs
-:- Biosynthesis, Storage, Secretion, and Metabolism of Thyroid Hormones
-:- Mechanisms of Action of Thyroid Hormones
-:- Physiological Effects of Thyroid Hormones
-:- Hypothyroid States
-:- Drugs Used in the Treatment of Hypothyroidism
-:- Adverse Effects of Treatment With Thyroid Hormone
-:- Thyroid and Antithyroid Drugs: Drug Interactions
-:- Thyrotoxicosis
-:- Drugs Used in the Treatment of Hyperthyroidism
-:- Calcium Homeostasis
-:- Parathyroid Hormone
-:- Calcitonin
-:- Vitamin D3 (Cholecalciferol)
-:- Bisphosphonates
-:- Clinical Uses of Parathyroid Hormone
-:- Parathyroid Hormone, Calcitonin, Vitamin D: Adverse Effects
-:- Glucose Homeostasis
-:- Insulin
-:- Diabetes Mellitus
-:- Metabolic Disturbances and Complications of the Diabetic State
-:- Clinical Management of Diabetes
-:- Oral Agents For Treating Diabetes Mellitus
-:- Sulfonylureas - Oral Agents For Treating Diabetes Mellitus
-:- Meglitinides - Oral Agents For Treating Diabetes Mellitus
-:- Biguanides - Oral Agents For Treating Diabetes Mellitus
-:- Thiazolidinediones - Oral Agents For Treating Diabetes Mellitus
-:- α-Glucosidase Inhibitors - Oral Agents For Treating Diabetes Mellitus
-:- Dietary Reference Standards
-:- Vitamins Deficiency Diseases
-:- Vitamin Toxicity
-:- Physiological Function and Dietary Sources - Vitamins
-:- Vitamins: Therapeutic Uses
-:- Vitamin–Drug Interactions
-:- Anemia
-:- Herbal Medicine
-:- Herbal Medicine Traditions
-:- Herbal Medicine: Potential Concerns
-:- Herbal Medicine: Regulatory Issues
-:- Herbal Preparations: Echinacea
-:- Herbal Preparations: Feverfew
-:- Herbal Preparations: Ginkgo Biloba Leaf Extract
-:- Herbal Preparations: Ginseng
-:- Herbal Preparations: Kava
-:- Herbal Preparations: Milk Thistle
-:- Herbal Preparations: Saw Palmetto
-:- Herbal Preparations: St. John’s Wort
-:- Herbal Preparations: Soy and Other Phytoestrogens